Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 4, 2002, Pages 355-359

  Ramdani, Akli ^a   Mignon, Michel ^a   Samoyeau, Roland ^b  

^a BICHAT HOSPITAL   (France)

^b Laboratoires Byk France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GASTRIN BLOOD LEVEL; HUMAN; MALE; PH MEASUREMENT; STOMACH ACID SECRETION; STOMACH PH; ZOLLINGER ELLISON SYNDROME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRINS; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; SULFOXIDES; TIME FACTORS; ZOLLINGER-ELLISON SYNDROME;

EID: 0036114397     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Diagnosis and treatment of Zollinger-Ellison syndrome
2. Gastrinomas (Zollinger-Ellison syndrome)
3. Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome
4. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome
5. Efficacité comparée du lansoprazole et de l'oméprazole sur le pH intragastrique mesuré sur 24 heures et sur le débit acide basal chez 9 malades atteints de syndrome de Zollinger-Ellison
6. Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease
7. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders
8. Effet dose-réponse du lansoprazole chez des malades atteints d'un syndrome de Zollinger-Ellison
9. Preliminary results of the proton pump inhibitor pantoprazole in patients with Zollinger-Ellison syndrome
10. Management of Zollinger-Ellison patients with pantoprazole
11. Oral pantoprazole effectively maintains control of acid output in Zollinger-Ellison syndrome and idiopathic hypersecretion
12. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
13. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring